Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study (Q34092425)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study |
scientific article |
Statements
1 reference
Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study (English)
1 reference
Mark C Genovese
1 reference
Roy Fleischmann
1 reference
Daniel Furst
1 reference
Namieta Janssen
1 reference
John Carter
1 reference
Bhaskar Dasgupta
1 reference
Judy Bryson
1 reference
Benjamin Duncan
1 reference
Wei Zhu
1 reference
Patrick Durez
1 reference
Kosmas Kretsos
1 reference
18 March 2014
1 reference
1 reference
73
1 reference
1607-1615
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference